AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 6, 2006). doi:10.1152/ajpendo.00602.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/E922    most recent
00602.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ball, A.
Right arrow Articles by Mitchell, B.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ball, A.
Right arrow Articles by Mitchell, B.F.
Submitted on December 1, 2005
Accepted on May 24, 2006

Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism not involving Activator Protein-1

Allison Ball1, Jing Wei Wang1, Susan Wong1, Barbara Zielnik1, Jana Marie Mitchell2, Nanping Wang3, Michael B. Stemerman3, and B.F. Mitchell1*

1 Obstetrics & Gynecology and Physiology, University of Alberta, Edmonton, Canada
2 Obstetrics and Gynecology, University of Alberta, Edmonton, Canada
3 Division of Biomedical Sciences, University of California at Riverside, Riverside, California, United States

* To whom correspondence should be addressed. E-mail: brymitch{at}ualberta.ca.

Oxytocin (OT) is a potent uterine agonist. Its receptor (OTR) is a G-protein coupled receptor that is down regulated by prolonged exposure to OT. We hypothesized that activation of protein kinase C (PKC) mediated this OT-induced decrease in OTR expression. Diminished PKC activity in late pregnancy could underlie the increase expression of uterine OTR preceding labor onset. Using cell cultures of transformed human uterine myocytes, we determined the effects of PKC agonists and antagonists on the expression of OTR. We also explored the effects of over-expression of activator protein-1 (AP-1; a mediator of many PKC and phorbol ester-induced effects), using adenoviral expression vectors for the AP-1 subunits c-Jun and c-Fos. Stimulation of PKC using the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) caused a rapid, significant (P ? 0.05) increase in c-Jun and c-Fos concentrations but a significant decrease in mRNA for OTR within 6 h, followed by a significant decrease in OT-binding by 24 h. Adenoviral infection of the cells with expression vectors for c-Jun and c-Fos increased the AP-1 subunits but had no effect on OTR expression. Further, there were no changes in c-Fos or c-Jun levels in human intrauterine tissues around the time of labor onset, as measured by western analyses. We conclude that phorbol ester treatment decreases OTR expression, likely through a mechanism that does not involve AP-1.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.